Clinical Trial Update: Cardiac Function in Patients With Hereditary Hemochromatosis

View source ↗

Summary

This clinical trial update reports cardiac function outcomes from a completed study in patients with hereditary hemochromatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hereditary Hemochromatosis | Status: COMPLETED